Jones Financial Companies

Jones Financial Companies’s Gain Therapeutics GANX Stock Holding History

Jones Financial Companies’s Portfolio GANX Stock Details GANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Sell	631,615 -70,598	-10%	-$154K	﹤0.01%	1659
2025 Q4	$2.26M	Buy	702,213 +25,391	+4%	+$67.8K	﹤0.01%	894
2025 Q3	$1.21M	Sell	676,822 -66	-0%	-$111	﹤0.01%	1061
2025 Q2	$1.33M	Buy	676,888 +249,188	+58%	+$461K	﹤0.01%	899
2025 Q1	$808K	Buy	427,700 +329,450	+335%	+$731K	﹤0.01%	944
2024 Q4	$212K	Buy	98,250 +44,750	+84%	+$89.8K	﹤0.01%	1327
2024 Q3	$106K	Buy	53,500 +46,500	+664%	+$58.4K	﹤0.01%	1376
2024 Q2	$8.96K	Buy	+7,000	New	+$18.2K	﹤0.01%	1788

Other funds holding GANX

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Potomac Capital Management New York $114M AUM

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return